Maneesh Khanna1, Abdul Rahman Abualruz2, Santosh K Yadav3, Mustafa Mafraji4, Khalid Al-Rumaihi5, Issam Al-Bozom6, Devendra Kumar7, Athina C Tsili8, Nicola Schieda9. 1. Wollongong Diagnostics, Wollongong, NSW, Australia. khanna.maneesh@gmail.com. 2. Department of Radiology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. 3. Sidra Medical and Research Center, Sidra Medicine, Doha, Qatar. 4. Department of Radiology, Rush University Medical Center, Chicago, IL, USA. 5. Department of Urology, Hamad Medical Corporation, Doha, Qatar. 6. Department of Lab Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar. 7. Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar. 8. Department of Clinical Radiology, University of Ioannina, University Campus, Ioannina, Greece. 9. Department of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Abstract
PURPOSE: Testicular stromal tumors are uncommon, although mostly benign. The purpose of this study is to assess the role of multi-parametric MRI in differentiating benign testicular stromal tumors from malignant testicular neoplasms (non-stromal and stromal). METHODS: A single-center retrospective study comparing benign stromal tumors (STs) to malignant testicular neoplasms (MTNs) was conducted. MR imaging assessment included tumor size, T2- and T1-weighted signal intensity, T2- and T1-weighted texture pattern, diffusion restriction, presence of hemorrhage and/or necrosis, and measurement of apparent diffusion coefficient and dynamic contrast enhancement (DCE). Inter-observer agreement was assessed using Cohen's kappa and Bland-Altman and data were compared using independent t-tests or χ2. Receiver operating characteristic curve analysis was used to test models incorporating various imaging features. RESULTS: Radical orchiectomy and histopathology revealed 20 testicular neoplasms: seven STs (35%) and thirteen MTNs (65%). MTNs were significantly larger in size than STs (5.1 ± 2.36 cm vs. 1.27 ± 0.56 cm; p-value < 0.001). STs demonstrated more hypointense T2W signal (85.7% vs. 46.2%; p-value < 0.09), less T2W heterogeneous texture (14.3% vs. 61.5%; p-value < 0.04), and less diffusion restriction (16.7% vs. 83.3%; p-value < 0.01) in comparison to MTNs. STs demonstrated mainly homogenous post-contrast enhancement pattern (71.4% vs. 7.7%; p-value < 0.004), while MTNs showed primarily heterogeneous enhancement pattern (77% vs. 14.3%; p-value < 0.02). STs revealed greater corrected venous phase enhancement (STs: 0.59 ± 0.29; MTNs: 0.25 ± 0.25; p-value < 0.03). STs showed higher ADC values, though the difference was not statistically significant (p-value < 0.25). A model combining T2W, DWI, and DCE features showed the best overall diagnostic accuracy with area under ROC curve of 0.99 and confidence interval ranging from 0.94 to 1. CONCLUSION: Multi-parametric MRI can potentially differentiate benign stromal tumors from malignant testicular neoplasms, which can help to avoid radical orchiectomy. However, future studies using larger sample sizes are needed to validate our results.
PURPOSE: Testicular stromal tumors are uncommon, although mostly benign. The purpose of this study is to assess the role of multi-parametric MRI in differentiating benign testicular stromal tumors from malignant testicular neoplasms (non-stromal and stromal). METHODS: A single-center retrospective study comparing benign stromal tumors (STs) to malignant testicular neoplasms (MTNs) was conducted. MR imaging assessment included tumor size, T2- and T1-weighted signal intensity, T2- and T1-weighted texture pattern, diffusion restriction, presence of hemorrhage and/or necrosis, and measurement of apparent diffusion coefficient and dynamic contrast enhancement (DCE). Inter-observer agreement was assessed using Cohen's kappa and Bland-Altman and data were compared using independent t-tests or χ2. Receiver operating characteristic curve analysis was used to test models incorporating various imaging features. RESULTS: Radical orchiectomy and histopathology revealed 20 testicular neoplasms: seven STs (35%) and thirteen MTNs (65%). MTNs were significantly larger in size than STs (5.1 ± 2.36 cm vs. 1.27 ± 0.56 cm; p-value < 0.001). STs demonstrated more hypointense T2W signal (85.7% vs. 46.2%; p-value < 0.09), less T2W heterogeneous texture (14.3% vs. 61.5%; p-value < 0.04), and less diffusion restriction (16.7% vs. 83.3%; p-value < 0.01) in comparison to MTNs. STs demonstrated mainly homogenous post-contrast enhancement pattern (71.4% vs. 7.7%; p-value < 0.004), while MTNs showed primarily heterogeneous enhancement pattern (77% vs. 14.3%; p-value < 0.02). STs revealed greater corrected venous phase enhancement (STs: 0.59 ± 0.29; MTNs: 0.25 ± 0.25; p-value < 0.03). STs showed higher ADC values, though the difference was not statistically significant (p-value < 0.25). A model combining T2W, DWI, and DCE features showed the best overall diagnostic accuracy with area under ROC curve of 0.99 and confidence interval ranging from 0.94 to 1. CONCLUSION: Multi-parametric MRI can potentially differentiate benign stromal tumors from malignant testicular neoplasms, which can help to avoid radical orchiectomy. However, future studies using larger sample sizes are needed to validate our results.
Authors: Athina C Tsili; Michele Bertolotto; Ahmet Tuncay Turgut; Vikram Dogra; Simon Freeman; Laurence Rocher; Jane Belfield; Michal Studniarek; Alexandra Ntorkou; Lorenzo E Derchi; Raymond Oyen; Parvati Ramchandani; Mustafa Secil; Jonathan Richenberg Journal: Eur Radiol Date: 2017-07-11 Impact factor: 5.315
Authors: Y Watanabe; M Dohke; K Ohkubo; T Ishimori; Y Amoh; A Okumura; K Oda; T Hayashi; Y Dodo; Y Arai Journal: Radiology Date: 2000-10 Impact factor: 11.105
Authors: Courtney Coursey Moreno; William C Small; Juan C Camacho; Viraj Master; Nima Kokabi; Melinda Lewis; Matthew Hartman; Pardeep K Mittal Journal: Radiographics Date: 2015 Mar-Apr Impact factor: 5.333
Authors: Oliver K Mohrs; Henrik Thoms; Tobias Egner; Anne Brunier; Michael Eiers; Hans-Ulrich Kauczor; Peter Hallscheidt Journal: AJR Am J Roentgenol Date: 2012-09 Impact factor: 3.959
Authors: Ahmed Mohamed Algebally; Hazim Ibrahim Tantawy; Reda Ramadan Hussein Yousef; Wojciech Szmigielski; Adham Darweesh Journal: Pol J Radiol Date: 2015-09-25
Authors: Athina C Tsili; Nikolaos Sofikitis; Ourania Pappa; Christina K Bougia; Maria I Argyropoulou Journal: Cancers (Basel) Date: 2022-08-13 Impact factor: 6.575